Cargando…
Corticosteroid treatment in severe COVID-19 pneumonia: two cases and literature review
Coronavirus disease 2019 (COVID-19) pneumonia, firstly reported in Wuhan, Hubei province, China, has rapidly spread around the world with high mortality rate among critically ill patients. The use of corticosteroids in COVID-19 remains a major controversy. Available evidences are inconclusive. Accor...
Autores principales: | Dai, Jinghong, Xiong, Yali, Li, Hui, Qian, Yajun, Xu, Ying, Xu, Qingqing, Yan, Xin, Tang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247779/ https://www.ncbi.nlm.nih.gov/pubmed/32451729 http://dx.doi.org/10.1007/s10067-020-05172-7 |
Ejemplares similares
-
Corticosteroid minimization in renal transplantation: Careful patient selection enables feasibility
por: Vlachopanos, Georgios, et al.
Publicado: (2016) -
Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed
por: Daoussis, Dimitrios, et al.
Publicado: (2021) -
CORTICOSTEROID TREATMENT IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA
por: Hong, Gloria, et al.
Publicado: (2020) -
Corticosteroids as Adjunctive Therapy in Severe Community-Acquired Pneumonia
por: Cillóniz, C., et al.
Publicado: (2016) -
Anti-IL5 Monoclonal Antibodies Reduce Asthma Exacerbations and Corticosteroids Dose in Three Eosinophilic Granulomatosis with Polyangiitis Case Reports
por: Skouvaklidou, Elpida, et al.
Publicado: (2023)